跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Menarini International Operations Luxembourg S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 15, 2024
Approval ID
490de59bff7504b5
Company
Menarini International Operations Luxembourg S.A.
Type
Standard
Approval Details
Approval Id
490de59bff7504b5
Drug Cima Aemps Name
BALZAK 40MG/5MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
20080197
Holder Company Name
Menarini International Operations Luxembourg S.A.
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Authorization Date
2024-11-15
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40/5 mg/mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Menarini International Operations Luxembourg S.A.
Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Company Information
Pharmaceutical Company Name
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Country Name
Luxembourg
City Name
luxembourg,country_lu
Address
Avenue de la Gare 1
Active Ingredients
OLMESARTAN MEDOXOMILO
40,000 mg
AMLODIPINO BESILATO
6,944 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 15, 2024
Approval ID
490de59bff7504b5
Type
Standard
Back to CIMA-AEMPS Approvals